Literature DB >> 25632194

Optimal duration of the early and late recurrence of hepatocellular carcinoma after hepatectomy.

Yusuke Yamamoto1, Hisashi Ikoma1, Ryo Morimura1, Hirotaka Konishi1, Yasutoshi Murayama1, Shuhei Komatsu1, Atsushi Shiozaki1, Yoshiaki Kuriu1, Takeshi Kubota1, Masayoshi Nakanishi1, Daisuke Ichikawa1, Hitoshi Fujiwara1, Kazuma Okamoto1, Chouhei Sakakura1, Toshiya Ochiai1, Eigo Otsuji1.   

Abstract

AIM: To determine the best cut-off value between the early and late recurrence periods after the initial recurrence of hepatocellular carcinoma (HCC).
METHODS: The clinical records of 404 patients who underwent macroscopic curative hepatectomy for HCC between 1980 and 2010 were retrospectively examined. We divided the 252 patients experienced a recurrence of HCC into two groups, the early and late recurrence groups using the "minimum P-value" approach. Factors for early recurrence were investigated using all 404 patients, and factors related to late recurrence were investigated in the patients who were confirmed to be recurrence free at the end of the early recurrence period.
RESULTS: For the 252 patients who experienced a recurrence, the optimal cut-off value for differentiating early and late recurrence based on the overall survival after initial recurrence was 17 mo (5-year overall survival after initial recurrence: 15.4% vs 36.3%, P=0.000018). Cox proportional hazard analysis identified early recurrence (P=0.003) as one of the independent prognostic factors associated with overall survival after initial recurrence. A logistic regression model showed that an alpha-fetoprotein level>100 ng/mL (P<0.001), multiple HCC (P<0.001), serosal invasion (P=0.031), and microvascular invasion (P=0.012) were independent factors associated with early recurrence, whereas the only independent factor related to late recurrence was liver cirrhosis (P=0.002).
CONCLUSION: Seventeen months after hepatectomy is a useful cut-off value between early and late recurrence of HCC based on the prognosis and different etiologies.

Entities:  

Keywords:  Early recurrence; Hepatectomy; Hepatocellular carcinoma; Late recurrence; Minimum P-value approach

Mesh:

Year:  2015        PMID: 25632194      PMCID: PMC4306165          DOI: 10.3748/wjg.v21.i4.1207

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  31 in total

1.  [Liver lobes and segments: notes on the anatomical architecture and surgery of the liver ].

Authors:  C COUINAUD
Journal:  Presse Med       Date:  1954-05-05       Impact factor: 1.228

2.  Liver resection for hepatocellular carcinoma in patients with cirrhosis.

Authors:  C-C Wu; S-B Cheng; W-M Ho; J-T Chen; T-J Liu; F-K P'eng
Journal:  Br J Surg       Date:  2005-03       Impact factor: 6.939

3.  Clinical trials of note. Sorafenib as adjuvant treatment in the prevention of disease recurrence in patients with hepatocellular carcinoma (HCC) (STORM).

Authors:  Carrie Printz
Journal:  Cancer       Date:  2009-10-15       Impact factor: 6.860

Review 4.  Meta-analysis: interferon improves outcomes following ablation or resection of hepatocellular carcinoma.

Authors:  A K Singal; D H Freeman; B S Anand
Journal:  Aliment Pharmacol Ther       Date:  2010-10       Impact factor: 8.171

5.  Analysis of risk factors associated with early multinodular recurrences after hepatic resection for hepatocellular carcinoma.

Authors:  Jung Ho Park; Kwang Cheol Koh; Moon Suk Choi; Joon Hyoek Lee; Byung Chul Yoo; Seung Woon Paik; Jong Chul Rhee; Jae Won Joh
Journal:  Am J Surg       Date:  2006-07       Impact factor: 2.565

6.  Type, density, and location of immune cells within human colorectal tumors predict clinical outcome.

Authors:  Jérôme Galon; Anne Costes; Fatima Sanchez-Cabo; Amos Kirilovsky; Bernhard Mlecnik; Christine Lagorce-Pagès; Marie Tosolini; Matthieu Camus; Anne Berger; Philippe Wind; Franck Zinzindohoué; Patrick Bruneval; Paul-Henri Cugnenc; Zlatko Trajanoski; Wolf-Herman Fridman; Franck Pagès
Journal:  Science       Date:  2006-09-29       Impact factor: 47.728

7.  Adjuvant intra-arterial iodine-131-labeled lipiodol for resectable hepatocellular carcinoma: a prospective randomized trial-update on 5-year and 10-year survival.

Authors:  Wan Yee Lau; Eric C H Lai; Thomas W T Leung; Simon C H Yu
Journal:  Ann Surg       Date:  2008-01       Impact factor: 12.969

8.  Risk factors for intrahepatic recurrence after hepatectomy for hepatocellular carcinoma.

Authors:  Salleh Ibrahim; Anupama Roychowdhury; Tay Khoon Hean
Journal:  Am J Surg       Date:  2007-07       Impact factor: 2.565

9.  A prospective clinical study on early recurrence of hepatocellular carcinoma after hepatectomy.

Authors:  Xin Lu; Haitao Zhao; Huayu Yang; Yilei Mao; Xinting Sang; Ruoyu Miao; Yiyao Xu; Shunda Du; Haifeng Xu; Tianyi Chi; Zhiying Yang; Shouxian Zhong; Jiefu Huang
Journal:  J Surg Oncol       Date:  2009-11-01       Impact factor: 3.454

10.  Analysis of prognostic factors affecting survival after initial recurrence and treatment efficacy for recurrence in patients undergoing potentially curative hepatectomy for hepatocellular carcinoma.

Authors:  Kazuaki Shimada; Yoshihiro Sakamoto; Minoru Esaki; Tomoo Kosuge; Chigusa Morizane; Masafumi Ikeda; Hideki Ueno; Takuji Okusaka; Yasuaki Arai; Kenichi Takayasu
Journal:  Ann Surg Oncol       Date:  2007-05-15       Impact factor: 5.344

View more
  33 in total

1.  Prognosis of Hepatocellular Carcinoma Patients Who Achieved Long-Term Recurrence-Free Survival After Curative Therapy: Impact of the ALBI Grade.

Authors:  Hajime Matsushima; Yuko Takami; Tomoki Ryu; Munehiro Yoshitomi; Masaki Tateishi; Yoshiyuki Wada; Hideki Saitsu
Journal:  J Gastrointest Surg       Date:  2018-05-07       Impact factor: 3.452

2.  The Prognostic Impact of the Lymphocyte-to-Monocyte Ratio in Resected Pancreatic Head Adenocarcinoma.

Authors:  Shunsuke Onoe; Atsuyuki Maeda; Yuichi Takayama; Yasuyuki Fukami; Takamasa Takahashi; Masahito Uji; Yuji Kaneoka
Journal:  Med Princ Pract       Date:  2019-05-20       Impact factor: 1.927

3.  Actual 10-Year Survivors After Resection of Hepatocellular Carcinoma.

Authors:  Jian Zheng; Deborah Kuk; Mithat Gönen; Vinod P Balachandran; T Peter Kingham; Peter J Allen; Michael I D'Angelica; William R Jarnagin; Ronald P DeMatteo
Journal:  Ann Surg Oncol       Date:  2016-12-05       Impact factor: 5.344

4.  Preoperative Prediction of Microvascular Invasion in Hepatocellular Carcinoma Using Quantitative Image Analysis.

Authors:  Jian Zheng; Jayasree Chakraborty; William C Chapman; Scott Gerst; Mithat Gonen; Linda M Pak; William R Jarnagin; Ronald P DeMatteo; Richard K G Do; Amber L Simpson
Journal:  J Am Coll Surg       Date:  2017-09-21       Impact factor: 6.113

5.  Risk Factors, Patterns, and Outcomes of Late Recurrence After Liver Resection for Hepatocellular Carcinoma: A Multicenter Study From China.

Authors:  Xin-Fei Xu; Hao Xing; Jun Han; Zhen-Li Li; Wan-Yee Lau; Ya-Hao Zhou; Wei-Min Gu; Hong Wang; Ting-Hao Chen; Yong-Yi Zeng; Chao Li; Meng-Chao Wu; Feng Shen; Tian Yang
Journal:  JAMA Surg       Date:  2019-03-01       Impact factor: 14.766

Review 6.  Intrahepatic recurrence of hepatocellular carcinoma after resection: an update.

Authors:  Maria Tampaki; George Vasileios Papatheodoridis; Evangelos Cholongitas
Journal:  Clin J Gastroenterol       Date:  2021-03-27

7.  Cadherin 17 is related to recurrence and poor prognosis of cytokeratin 19-positive hepatocellular carcinoma.

Authors:  Chao-Wei Lee; Sey-En Lin; Hsin-I Tsai; Po-Jung Su; Chia-Hsun Hsieh; Yung-Chia Kuo; Chang-Mu Sung; Cheng-Yu Lin; Chi-Neu Tsai; Ming-Chin Yu
Journal:  Oncol Lett       Date:  2017-11-01       Impact factor: 2.967

8.  Identification of Actual 10-Year Survival After Hepatectomy of HBV-Related Hepatocellular Carcinoma: a Multicenter Study.

Authors:  Zhen-Li Li; Wen-Tao Yan; Jin Zhang; Yi-Jun Zhao; Wan Yee Lau; Xian-Hai Mao; Yong-Yi Zeng; Ya-Hao Zhou; Wei-Min Gu; Hong Wang; Ting-Hao Chen; Jun Han; Hao Xing; Han Wu; Chao Li; Ming-Da Wang; Meng-Chao Wu; Feng Shen; Tian Yang
Journal:  J Gastrointest Surg       Date:  2018-10-17       Impact factor: 3.452

Review 9.  Association between Loss of Skeletal Muscle Mass and Mortality and Tumor Recurrence in Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis.

Authors:  Ke-Vin Chang; Jin-De Chen; Wei-Ting Wu; Kuo-Chin Huang; Chia-Tzu Hsu; Der-Sheng Han
Journal:  Liver Cancer       Date:  2017-12-09       Impact factor: 11.740

10.  Pattern of disease recurrence and its implications for postoperative surveillance after curative hepatectomy for hepatocellular carcinoma: experience from a single center.

Authors:  Kit-Fai Lee; Charing C N Chong; Anthony K W Fong; Andrew K Y Fung; Hon-Ting Lok; Yue-Sun Cheung; John Wong; Paul B S Lai
Journal:  Hepatobiliary Surg Nutr       Date:  2018-10       Impact factor: 7.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.